The healthcare industry continues to be a hotbed of innovation, with activity driven by telemedicine, real-time diagnostics, smart hospitals, and access to digital therapies, and the growing importance of technologies such as artificial intelligence (AI), the internet of things (IoT), augmented reality (AR), robotics, and data management practices. In the last three years alone, there have been over 106,000 patents filed and granted in the healthcare industry, according to GlobalData’s report on Robotics in Healthcare: Automated biochemistry analyzers.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
200+ innovations will shape the healthcare industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the healthcare industry using innovation intensity models built on over 443,000 patents, there are 200+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, microfluidic devices, static computer-aided implant surgery (s-CAIS), and digital pathology guided robotic surgery are disruptive technologies that are in the early stages of application and should be tracked closely. Interactive exercise system, computer-aided dental prostheses, and automated genetic screening are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas is the automated drug dispensing systems, which is now well established in the industry.
Innovation S-curve for robotics in the healthcare industry
Automated biochemistry analyser is a key innovation area in robotics
Fully automated biochemistry analysers are small, simple, and dependable instruments that can run tests on whole blood, serum, plasma, cerebrospinal fluid, or urine samples to assess the concentration of proteins, enzymes, electrolytes, metabolites, and even medications in the provided urine, blood, serum, plasma, or other body fluid samples.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 40+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of automated biochemistry analysers.
Key players in automated biochemistry analysers – a disruptive innovation in the healthcare industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to automated biochemistry analysers
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|F. Hoffmann-La Roche||187||Unlock company profile|
|Sysmex||152||Unlock company profile|
|Abbott Laboratories||96||Unlock company profile|
|Hitachi||89||Unlock company profile|
|Danaher||77||Unlock company profile|
|Labrador Diagnostics||72||Unlock company profile|
|Agilent Technologies||67||Unlock company profile|
|Caris MPI||42||Unlock company profile|
|Meso Scale Technologies||37||Unlock company profile|
|Koninklijke Philips||34||Unlock company profile|
|Siemens||31||Unlock company profile|
|Becton Dickinson and Co||30||Unlock company profile|
|Fujifilm Holdings||22||Unlock company profile|
|Inpeco Holding||22||Unlock company profile|
|Meso Scale Diagnostics||18||Unlock company profile|
|C. H. Boehringer Sohn||16||Unlock company profile|
|Thermo Fisher Scientific||15||Unlock company profile|
|Fio||14||Unlock company profile|
|Shimadzu||12||Unlock company profile|
|Bio-Rad Laboratories||12||Unlock company profile|
|DNAnudge||11||Unlock company profile|
|Hewlett Packard Enterprise||11||Unlock company profile|
|Elemental Scientific||10||Unlock company profile|
|Techno Medica||10||Unlock company profile|
|BioRad Laboratories||9||Unlock company profile|
|Laboratory Corp of America Holdings||8||Unlock company profile|
|Leavitt Medical||8||Unlock company profile|
|GE Healthcare||8||Unlock company profile|
|Toshiba||7||Unlock company profile|
|Johnson & Johnson||7||Unlock company profile|
|SYMAX||6||Unlock company profile|
|Yaskawa Electric||6||Unlock company profile|
|Alere Scarborough||6||Unlock company profile|
|Ems Pathology Medical Solutions||6||Unlock company profile|
|Mycenax Biotech||5||Unlock company profile|
|Essenlix||5||Unlock company profile|
|Shenzhen Mindray Bio-Medical Electronics||5||Unlock company profile|
|AT&T||5||Unlock company profile|
|Eppendorf||5||Unlock company profile|
|Nippon Chemi-Con||5||Unlock company profile|
|Boditech Med||5||Unlock company profile|
|Quidel||5||Unlock company profile|
Source: GlobalData Patent Analytics
In terms of application diversity, Thermo Fisher Scientific and Alere Scarborough are leading patent filers, followed by Abbott Laboratories. With regards to geographic reach, DNAnudge, Fio and Agilent Technologies are the leading companies.
Robotic automated biochemistry analysers can be cost effective, time saving, reliable and productive means of carrying out diagnosis.
To further understand the key themes and technologies disrupting the healthcare industry, access GlobalData’s latest thematic research report on Healthcare.